Outside of work, I love spending time with my family, traveling, and exploring the outdoors
As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide works by reducing appetite, influencing brain regions that control hunger, and slowing stomach emptying to help you feel fuller for longer
In March 2025, Roche and Zealand Pharma launched an Up-to-$5.3B obesity collaboration to co-develop and co-commercialize Zealands petrelintide for overweight and obesity indications
MNT had the opportunity to speak with Laurie Glasser, MD, a physical medicine and rehabilitation physician at Hackensack Meridian Healths Jersey Shore University Medical Center in New Jersey, as to why GLP-1 use might be linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity
Weight management : Older people have a reduced ability to produce glutathione naturally, which can lead to a reduced ability to burn fat, as well as weight gain
Structure and Chemical Properties Acetyl GLP-1 MAX belongs to the class of non-peptide class B1 GPCR agonists